Steven Cohen Tricida, Inc. Call Options Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.0 - $0.18 $0 - $23,796
-132,200 Closed
0 $0
Q4 2022

Feb 14, 2023
SELL
$0.14 - $12.49 $79,800 - $7.12 Million
-570,000 Reduced 81.17%
132,200 $19,000
Q3 2022

Nov 14, 2022
BUY
$8.51 - $13.6 $5.12 Million - $8.19 Million
602,200 Added 602.2%
702,200 $7.36 Million
Q2 2022

Aug 15, 2022
BUY
$7.31 - $11.85 $731,000 - $1.19 Million
100,000 New
100,000 $968,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email